PGF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Protagonist Therapeutics Inc

Watchlist Manager

Watchlist

Price: 75 EUR Market Closed

Market Cap: €2.9B

P	Protagonist Therapeutics Inc XBER:PGF	US
	Bureau Veritas SA F:4BV0	FR
S	Sage Group PLC DUS:SGK1	UK
	Bel Fuse Inc NASDAQ:BELFA	US
L	La-Z-Boy Inc SWB:LAZ	US
	Premier Foods PLC LSE:PFD	UK
	Stepan Co NYSE:SCL	US
	Gerresheimer AG OTC:GRRMF	DE
E	Endurance Technologies Ltd BSE:540153	IN
	WW International Inc NASDAQ:WW	US
W	West African Resources Ltd SWB:W25	AU
B	Badger Meter Inc F:33B	US
G	Green Brick Partners Inc NYSE:GRBK	US
R	Rotork PLC OTC:RTOXF	UK
F	Francotyp Postalia Holding AG XBER:FPH	DE
G	GlaxoSmithKline PLC F:GS7A	UK

Profitability Summary

Protagonist Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-192%

Negative 3Y Average Operating Margin

-46%

Negative Net Margin

-155%

Negative 3Y Average Net Margin

-27%

Negative Free Cash Flow Margin

-159%

Strong 3Y Average Free Cash Flow Margin

Negative 3Y Average ROIC

-257%

ROIC is Increasing

-1.494% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.